Assistant Professor, Director of Brachytherapy

Dr. Silva earned his bachelor’s degree at The University of Texas at Austin and then completed the M.D./Ph.D. program at the University of Kentucky. Following medical school, he completed an internship in general surgery at Vanderbilt University, in Nashville, TN and residency in Radiation Oncology at Loyola University in Chicago, IL. Upon completion of residency, he received the RSNA Roentgen Resident Award for research on brachytherapy. His clinical focus is gynecologic and GU cancers, with a specific interest in applying brachytherapy, using radioactive sources in an internal fashion, to the management of these malignancies.

Education/Training

Positions and Honors

Other Experience and Professional Memberships

Honors and Awards

• Radiological Society of North America Trainee Research Prize, November 2017
• Radiological Society of North America Roentgen Resident / Fellow Research Award, June 2018
• Selected for NextGen Brachy Program through the American Brachytherapy Society, October 2020

Selected Publications in Peer-Reviewed Journals

Matthew M. Harkenrider, MD, Fiori Alite, MD, Scott R. Silva, MD, PhD, William Small, Jr., MD. Image-Based Brachytherapy for the Treatment of Cervical Cancer. International Journal of Radiation Oncology, Biology, Physics, 92 (4): 921-934, July 15, 2015.

Kyle Stang, Scott Silva, Alec M. Block, James S. Welsh. THE INTEGRATION OF RADIATION THERAPY AND IMMUNOTHERAPY IN MELANOMA MANAGEMENT. Journal of Radiation Oncology, 5 (2): 131-142, June 2016.

Scott R. Silva, MD, PhD and Bahman Emami, MD.  Grade 3 radiation dermatitis in a patient with presumed latent actinic lichen planus. Advances in Radiation Oncology, 1 (3): 157-160, July-September 2016.

Scott R. Silva, MD, PhD, Murat Surucu, PhD, Jennifer Steber, CMD, Matthew M Harkenrider, MD and Mehee Choi, MD.  CLINICAL Application of a Hybrid RapidArc Radiotherapy Technique for Locally Advanced Lung Cancer. Technology in Cancer Research & Treatment, 16 (2): 224-230, April 2017.

Alec M. Block, Scott R. Silva, James S. Welsh. LOW-DOSE TOTAL BODY IRRADIATION: AN OVERLOOKED CANCER IMMUNOTHERAPY TECHNIQUE. Journal of Radiation Oncology, 6 (2): 109-115, June 2017.

Scott R. Silva, Anil Sethi, Vikram Prabhu, Douglas Anderson, Edward Melian.  PROGNOSTIC FACTORS AFFECTING OVERALL SURVIVAL AND LOCAL RECURRENCE IN MENINGIOMA PATIENTS TREATED WITH RADIOTHERAPY OR COMBINED RADIOTHERAPY AND SURGERY. Journal of Radiation Oncology, 7 (1): 27-35, March 2018. 

Karina Nieto, Brendan Martin, Nghia Pham, Laura Palmere, Scott R. Silva,Abigail Winder, Margaret Liotta, Ronald K. Potkul, William Small Jr., Matthew M. Harkenrider.  DOES ADJUVANT CONCURRENT OR SEQUENTIAL CHEMOTHERAPY INCREASE THE RADIATION-RELATED TOXICITY OF VAGINAL BRACHYTHERAPY FOR ENDOMETRIAL CANCER PATIENTS? Brachytherapy, 17 (6): 929-934, November-December 2018.

Aman Chauhan, Zainab Farooqui, Scott R. Silva, LeAundra Murray, Kurt B Hodges, Qian Yu, Zin W. Myint, Arumugam K. Raajesekar, Heidi Weiss, B. Mark Evers, Susanne Arnold, Lowell Anthony.  Integrating a 92-Gene Expression Assay in the Management of Neuroendocrine Tumors of Unknown Primary. Asian Pacific Journal of Cancer Prevention, 20 (1): 113-116, January 25, 2019.

Scott R. Silva, Adam Gliniewicz, Brendan Martin, Vikram C. Prabhu, Anand V. Germanwala, Edward Melian, G. Alex Jones, Abhishek A. Solanki.  OLIGOMETASTATIC DISEASE STATE IS ASSOCIATED WITH IMPROVED LOCAL CONTROL IN PATIENT UNDERGOING 3 OR 5 FRACTION SPINE STEREOTACTIC BODY RADIOTHERAPY. World Neurosurgery, 122: e342-e348, February 2019.

Scott R. Silva, MD, PhD, Brendan Martin, PhD, Mehee Choi, MD, Bahman Emami, MD, Newton Hurst, MD, PhD.  A NATIONAL CANCER DATABASE ANALYSIS OF THE EFFECT OF BRACHYTHERAPY ON OVERALL SURVIVAL IN PATIENTS WITH BASE OF TONGUE CANCER. Head & Neck, 41 (5): 1184-1192, May 2019.

Scott R. Silva, Jeremy T. Gaskins, Matthew R. Nichols, Daniel S. Metzinger, Sarah L. Todd, Harriet B. Eldredge-Hindy.  CERVICAL CANCER INCIDENCE AND MORTALITY RATES IN KENTUCKY.  Gynecologic Oncology, 158 (2): 446-451, August 2020.

Leonid B. Reshko, Jeremy T. Gaskins, Daniel S. Metzinger, Sarah L. Todd, Harriet B. Eldredge-Hindy, Scott R. Silva.  THE IMPACT OF BRACHYTHERAPY BOOST AND RADIOTHERAPY TREATMENT DURATION ON SURVIVAL IN VAGINAL CANCER PATIENTS TREATED WITH DEFINITIVE CHEMORADIATION.  Brachytherapy, 20 (1): 75-84, January-February 2021.

Leonid B. Reshko, Jeremy T. Gaskins, Sara Dryden, Daniel S. Metzinger, Sarah L. Todd, Harriet B. Eldredge-Hindy, Scott R. Silva.  The Role of Adjuvant Chemotherapy in FIGO Stage IB Grade 3 Endometrial Endometrioid Adenocarcinoma patients Treated with Surgery and Postoperative Radiotherapy.  International Journal ofGynecological Cancer, 31 (5): 694-701, May 2021.

Garrett Lee Jensen, Parul N. Barry, Harriet Eldredge-Hindy, Scott R. Silva, Sarah Todd, Kendall Hammonds, Daniel S Metzinger, Moataz El-Ghamry.  VAGINAL CUFF BRACHYTHERAPY: DO WE NEED TO TREAT MORE THAN A TWO-CENTIMETER ACTIVE LENGTH?  Journal of ContemporaryBrachytherapy, 13 (3): 294-301, May 2021.

Matthew R. Nichols, Jeremy T. Gaskins, Daniel S. Metzinger, Sarah L. Todd, Harriet B. Eldredge-Hindy, Scott R. Silva.  TRENDS IN INCIDENCE AND MORTALITY RATES OF UTERINE CANCER IN KENTUCKY.  Southern Medical Journal, 114 (10): 630-635, October 2021.

Leonid B. Reshko, Jeremy T. Gaskins, Abbas Rattani, Alyssa A. Farley, Grant W. McKenzie, Scott R. Silva. PATTERNS OF CARE AND OUTCOMES OF RADIOTHERAPY OR HORMONE THERAPY IN PATIENTS WITH MEDICALLY INOPERABLE ENDOMETRIAL ADENOCARCINOMA. Gynecologic Oncology, 163 (3): 517-523, December 2021.

Sara M. Dryden, Leonid B. Reshko, Jeremy T. Gaskins, Scott R. Silva. VERRUCOUS CARCINOMA OF THE VULVA: PATTERNS OF CARE AND TREATMENT OUTCOMES. Cancer Reports, 5 (10): e21591, October 2022.